Primary care

A multifaceted, clinic-level intervention results in a marked increase in the proportion of people with type 2 diabetes and atherosclerotic cardiovascular disease receiving appropriate medications, shows the COORDINATE randomized trial.

Formal recognition of type 2 diabetes remission in primary care may lead to suboptimal health monitoring, a study suggests.

Researchers find that a single questionnaire item assessing vitality predicts major adverse cardiovascular events in people with type 2 diabetes.

Clinical complexity and treatment burden have both increased over recent years among people with diabetes in the USA, say researchers.

The proven cardiovascular benefits of SGLT2 inhibitors has not led doctors to prioritize their use in people at high risk, show findings from UK general practice.

Increased team-based continuity of care correlates with decreased risk for cardiovascular disease in people with type 2 diabetes, researchers report in Diabetes Care.

Physicians feel that nonalcoholic fatty liver disease is sidelined in type 2 diabetes management and should be formally incorporated into routine primary care pathways, say Australian researchers.

UK researchers find people with type 2 diabetes are increasingly being cared for in specialist settings, rather than by family doctors.